Over the past decades, some medical researchers and neuroscientists have been exploring the possible therapeutic effects of ...
Researchers have treated the first patient in the PRECISION 1 trial with Fyarro to assess the drug’s efficacy across several endpoints including survival among more than 100 patients with solid tumors ...
Subjective cognitive decline (SCD) is a preclinical stage of Alzheimer’s disease (AD), during which patients notice a change in cognitive performance. However, this change cannot be identified in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results